WEB NEWS

Contributed by Dr. Jitendra Pahlajani, Medical Oncology, HCG Cancer Centre Jaipur   Diabetes and cancer are fatal diseases that frequently co-exist. Both can be challenging to deal with on their own. Battling both diseases at the same time may add even more stress to life. Studies have reported an increased risk of cancer diagnosis in patients with diabetes. The tumour or cancer therapies can cause uncontrolled sugar levels in diabetic patients. These uncontrolled sugars lead to a greater risk of mortality for many malignancies. The management of diabetes in cancer patients is often complicated by various factors. The treating physicians have to consider a lot of factors such as what level of  glycaemic control  is helpful, which therapy to use, how to deal with therapies, patient's dietary needs, how  diabetes complications  can affect cancer management and drug interactions, etc.  It is important to carefully manage the disease during and after cancer treatment if you have diabet

by Priya j ·           Investment builds on Advent’s expertise in the pharmaceuticals sector, having invested in over 20 businesses in pharmaceutical R&D, production, and distribution ·           Transaction is Advent’s fifth investment in India over the past 12 months New Delhi,INDIA,January, 2022  – Advent International (“Advent”),  one of the largest and most experienced global private equity investors, today announced that it has signed a definitive agreement with Dr A V Rama Rao, a distinguished scientist, Padma Bhushan and Padma Shri awardee, and his family to acquire a controlling stake in Avra Laboratories Pvt Limited (“Avra Labs”). Founded  in 1995, Avra Labs is a Hyderabad based contract manufacturing and research services (CRAMs) and specialty active pharmaceutical ingredients (API) manufacturer with four facilities across the states of Telangana and Andhra Pradesh. Avra Laboratories is a science-driven organisation with a strong research and development (‘R&D’) team

by Priya J Mr. Rajiv Mehrishi has been appointed as the Chairman of the Governing Board of NSE IFSC Limited (“NSE IFSC” - NSE’s International Exchange in GIFT city) effective January 25, 2022. The International Financial Services Centres Authority (IFSCA) had earlier approved his appointment as Public Interest Director (PID) on the Governing Board of NSE IFSC with effect from December 09, 2021.   Mr. Mehrishi, a retired  Indian Administrative Service  (IAS) officer, was the 13th  Comptroller and Auditor General of India  (C&AG) (2017 – 20) and Vice Chairman of the  United Nations  Panel of External Auditors. A few of his prior roles include being  Finance Secretary  (2014 - 15),  Home Secretary   (2015 - 17) and the Chief Secretary,  Government of Rajasthan  (2013 - 14).  He holds a master’s degree in History from  St. Stephen's College , Delhi and a degree in  Business Administration  from  Strathclyde Business School ,  Glasgow .  The Board and the management of NSE IFSC welc

 by Priya J Vaccination drive conducted across 434 Ujjivan SFB branches across 19 states, union territory Contributes INR 3,06,000 to Prime Minister’s Care Fund in FY 20-21, In FY 21-22 our objective is to contribute Rs. 10,00,000/-   to   Prime Minister’s Care Fund New Delhi, January , 2022:  Ujjivan Small Finance Bank today announced that it had achieved landmark of 50,000 vaccinations amongst the low-income population residing in urban, semi-urban and remote rural geography in just less than 5 months, organizing vaccination camps for the general public coming within the purview of the Bank’s Operational areas and those in the vicinity across 434 branches in 18 states and union territory of Puducherry. The bank now aims to achieve another 50,000 vaccinations within these lower-income groups, including those residing in remotest locations to achieve overall 100,000 vaccinations by March 31,2022. Ujjivan SFB has attributed the success in achieving landmark vaccination to its own employ

    Ittira Davis, a veteran banker of international repute to lead Ujjivan Small Finance Bank by Priya J New Delhi: January 13, 2022 : Ujjivan Small Finance Bank today announced that it has received the RBI approval for the appointment of Mr. Ittira Davis as its Managing Director & CEO for a period of 1 (one) year. Mr Ittira Davis is a senior banker with over 40 years of rich experience having worked extensively in India, Middle East and Europe. He has been associated with Ujjivan since March 2015. His first pivotal assignment, as the Head of Transition, was to oversee successful transformation of a micro-finance institution into a small finance bank which included accessing the capital markets with two successful IPOs. Prior to Ujjivan, Mr. Davis was the Managing Director with the Europe Arab Bank, London. He has also held leadership positions with Arab Bank plc, Bahrain and Citibank, India.  He is an alumnus of Indian Institute of Management-Ahmedabad (IIM-A). Mr. B A Prabhakar,

The Investment will help  bolster the out-of-hospital care segment in the country - a critical need in view of shortage of hospitals to deliver the best possible health outcomes and quality of life for patients while increasing the access and affordability by Priya J New Delhi, January 13, 2022 :    Health-tech company  HCAH (HealthCare atHOME)  has raised Rs  112 crore from ABC World Asia (“ABC”), a Singapore based impact-focused private equity fund,  to help build India’s largest and most clinically accomplished out of hospital healthcare delivery platform.  HCAH will use this investment to build its presence in the  (i)  Physical rehabilitation and recovery through its  service range of Home ICU, Inpatient rehab in transition care centers, digital and home rehab; and rehab equipment  (ii)  Elderly care services including long term nursing, palliative and attendant care services  (iii)  Chronic Disease Management services including screening, diagnostics, patient support, adherence p

by Priya J Starts at ₹ 34.99 lacs with three trims on offer: Style, SportLine, and Laurin & Klement With its specific use of crystalline elements, KODIAQ has defined the ŠKODA SUV design language Dual strengths of power and efficiency with the new 2.0 TSI Engine, paired with 7 speed DSG and 4x4 capabilities The feature-rich all-new ŠKODA KODIAQ brings state-of-the-art tech and driving dynamics to the Indian consumer taking forward the value luxury proposition  Segment-best active and passive safety features with 9 airbags standard across all trims Segment-first Dynamic Chassis Control (DCC) which enables choice of 6 driving modes Fast mover: 0-100 : 7.8 seconds Mumbai, January,2022:  Four years after the ŠKODA KODIAQ thundered into the Indian market, ŠKODA has updated its internationally successful SUV with an even more refined and striking design language with improvements to the engine, chassis, driving dynamics, safety, in-cabin entertainment and connectivity and comfort and lux

by Priya J  At least 25% of people who experience a non-fatal heart attack or sudden death, have had no previous symptoms Doctors recommend that all adults   must get their heart checked for calcium deposits once a year through the heart calcium-score screening test NURA doctors are seeing 20% positive rate for heart calcium among people getting themselves tested BENGALURU / JANUARY 11, 2022 –  Increasing presence of calcium deposits in coronary arteries will gradually lead to their narrowing down, triggering a heart attack if preventive measures are not taken. Everyone above the age of 18, especially those with a family history of heart blockage, should undergo the calcium-score screening heart test once a year, recommend doctors of  NURA diagnostic centre , a collaboration between Fujifilm Healthcare and Dr. Kutty’s Healthcare. Said  Dr. Tausif Ahmed Thangalvadi, Medical Director, NURA : “A calcium-score screening heart test, also called coronary calcium scan, uses Computerized Tomog

by Priya J Key Highlights: No hypothecation, hassle free two-wheeler loan Attractive rate of interest, one of the lowest in the industry Quick Loan Approval in less than 3 minutes, Disbursal in 60 minutes Upto 90% value of the loan can be availed with a 4-year repayment scheme New Delhi, January 10, 2022 : L&T Finance, one of the leading two-wheeler financiers in India today announced the “Welcome 2022” loan for customers aspiring to buy Royal Enfield motorcycles. The scheme comes with no hypothecation and will offer hassle-free, quick loan approvals in under 3 minutes, at attractive interest rates (from 7.99% onwards) to customers who are looking to buy their favorite Royal Enfield motorcycles. The scheme will offer up to 90 percent financing of the total cost of the vehicle on a 4-year repayment which will serve as an added benefit for the customers. B Govindarajan, Executive Director, Royal Enfield  said “We’re happy to  partner with L&T Finance  to provide finance solutions

by Priya J Continued product offensive through 2022 with 6 launches Aims to triple sales over 2021, setting 2022 as the year for the highest ever sales Targets to increase customer touchpoints by more than 25% in 2022 Will introduce new initiatives to enhance customer satisfaction On track to achieve sales volumes of 1,00,000 units by 2025 India to be amongst the top ten markets for ŠKODA AUTO Mumbai, January 6 th , 2022:  The year 2022 is slated to be the biggest year for  ŠKODA AUTO India  ever since its entry into the Indian market in 2001. With a focused market strategy built around its consistent product launch campaigns, focus on enhancing the after sales and customer satisfaction drivers and increasing its network presence across the country, ŠKODA AUTO India plans to triple its annual sales volumes in 2022 and further build on the positive momentum created last year. From 10,387 cars sold in 2020, ŠKODA AUTO India achieved a triple digit growth   of 130% with 23,858 units sold